Nicole - Anti-Lipid Agents Flashcards

1
Q

What are the Categories for Anti-hyperlipidemia medications?

A
  1. HMG-CoA reductase inhibitors
  2. Bile acid sequestrants
  3. fabric acids
  4. nicotinic acid
  5. cholesterol absorption inhibitor
  6. other (Omega 3 fatty acid)
  7. PCSK9 Inhibitor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the high intensity statins?

They reduce LDL by >50%

A
  • Atorvastatin (lipitor) 40-80mg

- Rousuvastatin (crestor) 20-40mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the moderate intensity statins?

reduce LDL by 30-49%

A
Atorvastatin 10-20mg
Rosuvastatin 5-10mg
Simvastatin 20-40mg
Provastatin 40-80mg
Lovastatin 40mg
Fluvastatin 40mg BID
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the MOA of Atorvastatin

A

inhibits cholesterol synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the best combo LDL/Triglyceride reduction of the statins?

A

Atorvastatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are some important things to remember about Lovastatin

A

Use cautiously in decreased renal function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some important things to remember about Pravastatin

A

Not CYP450 metabolized

Caution in renal, hepatic dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are some important things to remember about Rosuvastatin?

A

Second most potent for combo LDL/Triglyceride reduction

Caution renal or hepatic dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are some important things to remember about Simvastatin

A

No longer use the 80mg dose

caution in renal dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are some important things to remember about Fluvastatin

A

Daily or twice daily dosing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the class of Cholestyramine

A

Bile acid sequestrant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the indications for cholestyramine?

A

Hypercholesterolemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cholestyramine is moderately effective lowering cholesterol but doesn’t lower what?

A

triglycerides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the class of colesevelam?

A

Bile acid sequestrant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the indications of Colesvelam

A

LDL reduction
DM2
Usually adjust therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the MOA of Colesevelam

A

Binds bile acids inhibiting enterohepatic circulation of cholesterol

17
Q

What is the class of Gemfibrozil?

18
Q

What are the indications of gemfibrozil

A

hypertriglyceridemia

Low LDL

19
Q

What drugs to you need to avoid with the use of gemfibrozil?

A

Clopidogrel
Repaglinide
Warfarin

20
Q

Fenofibrate is in what drug class?

21
Q

The Indications for fenofibrate are what?

A

Hypertriglyceridemia

Low HDL

22
Q

What are the most effective triglyceride lowering agents?

A

Gemfibrozil

Fenofibrate

23
Q

The vitamin B3 mediation is what?

A

Nicotinic acid

24
Q

The indications of Nicotinic acid includes what?

A

Hypertriglyceridemia
low HDL
high LDL

25
The MOA of nicotinic acid is what?
inhibits fatty acid release from adipose tissue and hepatic triglyceride production
26
Exetimibe is in what drug class?
Cholesterol absorption inhibitor
27
Why do you use exetimibe?
For Hypercholesterolemia
28
The MOA of Exetimibe is what?
Decreases absorption of cholesterol from GI tract
29
What are the indications for Omega 3 fatty acids?
High trig despite diet, alcohol restriction and fibrates
30
Evolocumab is in what drug class?
monoclonal antibody PCSK9 inhibitor
31
The indication of Evolocumab include what?
drug resistant hyperlipidemia | especially homozygous familial hypercholesterolemia
32
MOA of evolocumab
human monoclonal antibody that binds to proprotein convertase subtilisin kexin type 9 (PCSK9) inhibiting the degradation of LDLR; this increases the number of LDLRs available to clear LDL from the blood thereby lowering LDL-C levels